Zynex Announces Award of UK Patent for Non-Invasive Detection of Sepsis

Company Overview - Zynex, Inc. is an innovative medical technology company focused on noninvasive medical devices for pain management, rehabilitation, and patient monitoring [1][10] - The company has been awarded UK patent 2617515 for a multiparameter, noninvasive sepsis monitor [1] Industry Context - Sepsis is a critical global health issue, with over 1.7 million cases annually in the United States and a mortality rate that is among the highest for medical conditions [2][3] - Globally, sepsis results in approximately 11 million deaths each year, accounting for about 20% of total deaths, with a significant portion of cases occurring in children under 5 years old [2][3] Product Development - Zynex aims to develop a noninvasive, highly accurate sepsis monitor that continuously tracks multiple physiological signals to provide real-time alerts to clinicians [3][4] - The device is expected to enhance early detection and treatment of sepsis, potentially reducing mortality rates associated with this condition [4]